Sinclair Pharma PLC Company Profile (LON:SPH)

About Sinclair Pharma PLC (LON:SPH)

Sinclair Pharma PLC logoSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company's product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology. The Company provides aesthetic dermatology solutions through thread lift, collagen stimulation and dermal fillers. The Company's aesthetic products include Silhouette Soft, Ellanse, Perfectha, Sculptra and USOFT Massage Gel. Its Silhouette Soft is inserted in the subcutaneous tissue. Its USOFT Massage Gel is a gel used for facial massage. It is engaged in research and development, and owns various product rights and licenses in a range of territories in which it trades.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Generic Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:SPH
  • CUSIP: N/A
  • Web: www.sinclairispharma.com
Capitalization:
  • Market Cap: £134.34 million
  • Outstanding Shares: 502,198,000
Average Prices:
  • 50 Day Moving Avg: GBX 29
  • 200 Day Moving Avg: GBX 31.10
  • 52 Week Range: GBX 26 - GBX 36.35
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £30.33 million
  • Price / Sales: 4.43
  • Book Value: GBX 0.20 per share
  • Price / Book: 1.34
Profitability:
  • EBIDTA: ($11,710,000.00)
  • Net Margins: -42.69%
  • Return on Equity: -16.64%
  • Return on Assets: -9.47%
Misc:
  • Average Volume: 555,127 shs.
 

Frequently Asked Questions for Sinclair Pharma PLC (LON:SPH)

What is Sinclair Pharma PLC's stock symbol?

Sinclair Pharma PLC trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

Where is Sinclair Pharma PLC's stock going? Where will Sinclair Pharma PLC's stock price be in 2017?

6 brokerages have issued 12 month target prices for Sinclair Pharma PLC's shares. Their forecasts range from GBX 35 to GBX 71. On average, they anticipate Sinclair Pharma PLC's stock price to reach GBX 54 in the next year. View Analyst Ratings for Sinclair Pharma PLC.

Who are some of Sinclair Pharma PLC's key competitors?

Who are Sinclair Pharma PLC's key executives?

Sinclair Pharma PLC's management team includes the folowing people:

  • Christopher P. Spooner, Chief Executive Officer, Executive Director
  • Alan Olby, Chief Financial Officer
  • Jean-Louis Lamande, Operations Finance Director
  • Jayne Burrell, Group General Counsel, Company Secretary
  • Patrick Khoukaz, Head - European Operations and Global Aesthetics
  • Sarb Klair, Head - Corporate Development
  • Nairn McMaster, Head - Business Development
  • Grahame David Cook, Non-Executive Independent Chairman of the Board
  • Jean-Charles Tschudin, Senior Non-Executive Independent Director

How do I buy Sinclair Pharma PLC stock?

Shares of Sinclair Pharma PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sinclair Pharma PLC's stock price today?

One share of Sinclair Pharma PLC stock can currently be purchased for approximately GBX 26.75.


MarketBeat Community Rating for Sinclair Pharma PLC (LON SPH)
Community Ranking:  4.0 out of 5 (star star star star)
Outperform Votes:  303 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  379
MarketBeat's community ratings are surveys of what our community members think about Sinclair Pharma PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sinclair Pharma PLC (LON:SPH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: GBX 54

Analysts' Ratings History for Sinclair Pharma PLC (LON:SPH)
Show:
DateFirmActionRatingPrice TargetDetails
9/19/2017N+1 SingerReiterated RatingBuyGBX 37View Rating Details
9/19/2017Peel HuntReiterated RatingBuyGBX 68View Rating Details
7/11/2017Stifel NicolausReiterated RatingBuyGBX 71View Rating Details
4/4/2017Numis Securities LtdReiterated RatingHoldGBX 35View Rating Details
3/22/2017Jefferies Group LLCReiterated RatingBuyGBX 55View Rating Details
11/18/2016Canaccord GenuityReiterated RatingBuyGBX 58View Rating Details
9/15/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
9/28/2015Panmure GordonReiterated RatingUnder ReviewView Rating Details
9/28/2015InvestecDowngradeHoldView Rating Details
(Data available from 9/21/2015 forward)

Earnings

Earnings History for Sinclair Pharma PLC (LON:SPH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sinclair Pharma PLC (LON:SPH)
Current Year EPS Consensus Estimate: $-1.93 EPS

Dividends

Dividend History for Sinclair Pharma PLC (LON:SPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Sinclair Pharma PLC (LON:SPH)
Insider Trades by Quarter for Sinclair Pharma PLC (LON:SPH)
Insider Trades by Quarter for Sinclair Pharma PLC (LON:SPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2016Alan OlbyInsiderBuy6,748GBX 29£1,956.92
10/4/2016Jeff ThompsonInsiderBuy150,000GBX 29£43,500
5/27/2016Tschudin,Jean-CharlesInsiderBuy97,000GBX 36£34,920
5/26/2016Tschudin,Jean-CharlesInsiderBuy3,023GBX 35£1,058.05
5/23/2016Olby,AlanInsiderBuy50,000GBX 35£17,500
5/20/2016Foucher,ChristopheInsiderBuy31,500GBX 35£11,025
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Sinclair Pharma PLC (LON:SPH)
Latest Headlines for Sinclair Pharma PLC (LON:SPH)
Source:
DateHeadline
rttnews.com logoSinclair Pharma HY Loss Widens; On Track To Meet FY Guidance For EBITDA Profit
www.rttnews.com - September 19 at 7:56 AM
finance.yahoo.com logoWhy Sinclair Pharma plc (AIM:SPH) Could Be A Buy
finance.yahoo.com - September 14 at 10:29 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - September 12 at 1:34 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 29 at 6:44 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 4 at 6:50 AM
fool.co.uk logoCan these growth shares provide high total returns?
www.fool.co.uk - July 12 at 1:36 AM
morningstar.co.uk logoSinclair Pharma Silhouette Soft Product Drives Half Year Revenue Rise
www.morningstar.co.uk - July 12 at 1:36 AM
rttnews.com logoSinclair Pharma H1 Sales Climb; Says Confident Of Adj. EBITDA Profit For FY
www.rttnews.com - July 11 at 7:55 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 10 at 7:32 AM
americanbankingnews.com logoSinclair Pharma PLC's (SPH) "Buy" Rating Reaffirmed at Peel Hunt
www.americanbankingnews.com - June 19 at 9:28 PM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - June 13 at 7:32 AM
finance.yahoo.com logoSinclair Pharma Plc breached its 50 day moving average in a Bearish Manner : SPH-GB : May 29, 2017
finance.yahoo.com - May 29 at 6:31 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 19 at 7:50 AM
finance.yahoo.com logoSinclair Pharma Plc – Value Analysis (LONDON:SPH) : April 26, 2017
finance.yahoo.com - April 26 at 9:22 PM
finance.yahoo.com logoSinclair Pharma Plc :SPH-GB: Earnings Analysis: For the six months ended December 31, 2016 : April 26, 2017
finance.yahoo.com - April 26 at 9:22 PM
finance.yahoo.com logoSinclair Pharma Plc breached its 50 day moving average in a Bearish Manner : SPH-GB : April 25, 2017
finance.yahoo.com - April 25 at 9:43 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 24 at 7:33 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) PT Lowered to GBX 37
www.americanbankingnews.com - April 19 at 11:25 AM
finance.yahoo.com logoSinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : SPH-GB : April 14, 2017
finance.yahoo.com - April 14 at 12:29 PM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Rating Reiterated by Numis Securities Ltd
www.americanbankingnews.com - April 8 at 7:59 PM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Earns Buy Rating from Stifel Nicolaus
www.americanbankingnews.com - April 8 at 6:46 PM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 28 at 12:58 PM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Receives Buy Rating from Jefferies Group LLC
www.americanbankingnews.com - March 28 at 2:20 AM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Given "Buy" Rating at Peel Hunt
www.americanbankingnews.com - March 25 at 5:07 PM
americanbankingnews.com logoSinclair Pharma PLC (SPH) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - March 22 at 7:58 PM
americanbankingnews.com logoSinclair Pharma PLC's (SPH) Buy Rating Reaffirmed at N+1 Singer
www.americanbankingnews.com - March 21 at 10:00 PM
americanbankingnews.com logoSinclair Pharma PLC's (SPH) Buy Rating Reiterated at Stifel Nicolaus
www.americanbankingnews.com - March 21 at 12:04 PM
rttnews.com logoSinclair Pharma Loss Narrows; Sees Positive FY17 EBITDA; Settles With Alliance
www.rttnews.com - March 21 at 10:09 AM
uk.finance.yahoo.com logoBUZZ-Alliance Pharma: gains on deal settlement
uk.finance.yahoo.com - March 21 at 10:09 AM
biz.yahoo.com logoFull Year 2016 Sinclair Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - March 21 at 10:09 AM
lse.co.uk logoPre-Close Trading Update - London South East (registration) (blog)
www.lse.co.uk - January 18 at 2:46 AM
nasdaq.com logoSinclair Pharma H1 Revenues Surge; Affirms 2016 Outlook - Quick Facts
www.nasdaq.com - July 19 at 7:43 PM
uk.finance.yahoo.com logoDirector dealings: Jardine Matheson's Keswick sells shares
uk.finance.yahoo.com - May 23 at 1:18 PM
uk.finance.yahoo.com logoDon’t buy or sell Sinclair Pharma plc, Ladbrokes plc or Close Brothers Group plc until you’ve read this!
uk.finance.yahoo.com - May 20 at 6:20 AM
fool.co.uk logoShould You Buy Cap-XX Limited, Sinclair Pharma PLC And Manx Telecom PLC After Today's Results? - Motley Fool UK
www.fool.co.uk - March 30 at 2:36 PM
biz.yahoo.com logoHalf Year 2016 Sinclair Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - March 30 at 7:07 AM

Social

Social activity is not available for this stock.

Chart

Sinclair Pharma PLC (SPH) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff